A similar study could be executed with the AD Informer Set, which contains five different EPHX2 inhibitors, in the proposed iPSC‐based system to validate EPHX2 as a target in this patient‐derived AD model system. The gene discussed is EPHX2; the disease is Alzheimer disease.